Últimos artículos de revistas científicas

  • Error in Table
    en 01/09/2026 a las 00:00

    The Original Investigation titled “A Group Parenting Intervention for Male Postpartum Depression: A Cluster Randomized Clinical Trial,” published online first October 2, 2024, and in the January 2025 issue was corrected to fix an error in the […]

  • Psychedelics Trials and Outcomes—A Closer Look
    en 01/09/2026 a las 00:00

    To the Editor In the article by Williams et al in JAMA Psychiatry, comparison of efficacy data from (mostly double-blind randomized clinical trials) of psychedelic therapy (PT) vs open-label trials (OLTs) of traditional antidepressants (TADs) rests […]

  • Mapping 2-Year Psychiatric and Neurologic Risks After Infections
    en 01/09/2026 a las 00:00

    This cohort study investigates the association between infection and risks of psychiatric and neurologic disorders and how risks vary by body system affected and age.

  • Psychedelics Trials and Outcomes—A Closer Look—Reply
    en 01/09/2026 a las 00:00

    In Reply Our response to Nayak and colleagues is that our H2 (ie, blinded vs open-label traditional antidepressants [TADs]) was that the difference between open-label and blinded TAD trials will exceed the minimal clinically important difference […]

  • Gastrointestinal Interoception and Relapse in Anorexia Nervosa
    en 01/09/2026 a las 00:00

    This crossover trial examines behavioral, computational, neural, and physiological markers of gastrointestinal interoception in weight-restored individuals with anorexia nervosa and tests their association with relapse.

  • Evolution of Lithium as a Disease-Modifying Agent in Dementia
    en 01/09/2026 a las 00:00

    This narrative review synthesizes more than 75 years of evidence to evaluate lithium’s evolution from mood stabilizer to candidate neuroprotective intervention.

  • Lobbying Trends in Psychiatry and Psychology
    en 01/09/2026 a las 00:00

    This economic evaluation characterizes US lobbying spending in the mental health field between 2014 and 2024.

  • The Clinical Threshold for Treatment in Psychiatry
    en 01/09/2026 a las 00:00

    This Viewpoint highlights the determinants of treatment thresholds that should be considered for psychiatric care and explores the implications of recent developments in clinimetrics in this field.

  • Psychedelics Trials and Outcomes—A Closer Look
    en 01/09/2026 a las 00:00

    To the Editor In the article by Williams et al in JAMA Psychiatry, the authors state that “…blinded trials conceal treatment allocation…” and conclude that psychedelic-assisted therapy (PAT) trials are effectively open label. We argue that […]

  • Schizophrenia Spectrum and Dopaminergic Dysregulation
    en 01/09/2026 a las 00:00

    This Special Communication challenges the classical dopamine excess hypothesis as the final common pathway for pathophysiology of schizophrenia and related disorders as it does not adequately explain the full range of symptoms, particularly […]